New study hopes to ease chronic constipation with linaclotide
NCT ID NCT07431957
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two doses of linaclotide (72 mcg and 145 mcg) against a placebo in 90 adults with chronic constipation. Participants take the drug daily for 8 weeks and record their bowel movements and symptoms. The goal is to see if linaclotide improves bowel function and reduces discomfort better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dhaka Medical College
Dhaka, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••